PharmacoEconomics is dedicated to the clear communication of complex pharmacoeconomic issues related to all healthcare interventions (drugs, diagnostics, devices, personalized medicine and surgical interventions). The Journal includes:

Leading/current opinion articles providing an overview of contentious or emerging issues.
Definitive reviews of topics relating to the pharmacoeconomic and quality-of-life assessment of healthcare interventions and their outcomes.
Original research articles.

Editors (Adis International Limited, Auckland, New Zealand):
Christopher I. Carswell
Timothy Wrightson
Editorial Board:
A.H. Anis, University of British Columbia, Vancouver, BC, Canada
F. Antonanzas, University of La Rioja, Logroño, Spain
C. Asche, University of Illinois College of Medicine of Peora, Peoria, IL, USA
H. Birnbaum, Analysis Group, Inc., Boston, MA, USA
L. Bojke, University of York, York, England
J.L. Bootman, The University of Arizona, Tucson, AZ, USA
J.F.P. Bridges, The Ohio State University, Columbus, OH, USA
W.B.F. Brouwer, Institute for Medical Technology Assessment, Rotterdam, the Netherlands
J.J. Caro, McGill University, Concord, MA, USA
C-R. Chien, China Medical University & Hospital, Taichung, Taiwan
J. Darba, University of Barcelona, Barcelona, Spain
G.L. Di Tanna, The George Institute for Global Health, Sydney, NSW, Australia
H. Dong, Zhejiang University, Hangzhou, China
M.F. Drummond, University of York, York, England
R. Elliott, University of Manchester, Manchester, England
E. Fenwick, Pharmerit International, Oxford, England
N. Freemantle, University College London, London, England
D.A. Freund, Claremont Graduate University, CA, USA
S. Garattini, Mario Negri Institute, Milan, Italy
B.P. Geisler, Massachusetts General Hospital, Boston, MA, USA
A. Gerber-Grote, ZHAW School of Health Professions, Winterthur, Switzerland
S. Ghabri, French National Authority for Health (HAS), Paris, France
P. Greenberg, Analysis Group, Inc., Boston, MA, USA
W. Greiner, University of Bielefeld, Bielefeld, Germany
P. Hall, The University of Edinburgh, Edinburgh, Scotland
A.B. Hauber, RTI Health Solutions, NC, USA
A. Haycox, University of Liverpool Management School, Liverpool, England
S. Hill, WHO, Geneva, Switzerland
C.S. Hollenbeak, Pennsylvania State College of Medicine, Hershey, PA, USA
D. Hughes, Bangor University, Bangor, Wales
J. Jung, Pennsylvania State University, University Park, PA, USA
J. Karnon, Flinders University, South Australia, Adelaide, SA, Australia
E. Lancsar, The Australian National University, Canberra, ACT, Australia
N. Maniadakis, National School of Public Health, Athens, Greece
R.J. Milne, Health Outcomes Associates Limited, Auckland, New Zealand
A. Mühlbacher, Hochschule Neubrandenburg, Neubrandenburg, Germany
J. O’Mahony, Trinity College Dublin, Dublin, Ireland
E. Onukwugha, University of Maryland, Baltimore, MD, USA
M. Paulden, University of Alberta, Edmonton, AB, Canada
S. Petrou, University of Oxford, Oxford, England
L. Pizzi, Rutgers University, Piscataway, NJ, USA
L. Prosser, University of Michigan, Ann Arbor, MI, USA
J.P. Raftery, University of Southampton, Southampton, England
J. Rovira, University of Barcelona, Barcelona, Spain
G.T. Schumock, University of Illinois at Chicago, Chicago, IL, USA
D.A. Sclar, Midwestern University Glendale, AZ, USA
M. Sculpher, University of York, York, England
L. Shi, Tulane University, New Orleans, LA, USA
Y.-C.T. Shih, University of Texas MD Anderson Cancer Center, Houston, TX, USA
M. Singer, Case Western Reserve University, Cleveland, OH, USA
C. Skedgel, Office of Health Economics, London, England
E. Stolk, EuroQOL, Rotterdam, the Netherlands
T.D. Szucs, University of Basel, Zurich, Switzerland
P. Tappenden, University of Sheffield, Sheffield, England
T. Wisløff, NorwegianInstitute of Public Health, Oslo, Norway